Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood.

Medicine & Life Sciences

• Beauty 68%
• Antigen-Presenting Cells 53%
• Fetal Blood 50%
• T-Lymphocytes 31%
• Neoplasm Antigens 18%
• Transposases 16%
• human sleeping beauty transposase 14%
• Plasmids 13%
• Transgenes 11%
• DNA 9%
• Clone Cells 8%
• Dinucleotide Repeats 8%
• interleukin-21 7%
• Viruses 7%
• Interleukin-15 7%
• Fc Receptors 6%
• Lentivirus 6%
• Retroviridae 6%
• Tumor Microenvironment 5%
• Biological Products 5%
• Genetic Therapy 5%
• Immunotherapy 4%
• Immunoglobulin G 4%
• Monoclonal Antibodies 4%
• Neoplasms 3%
• Peptides 3%
• Costs and Cost Analysis 3%
• Membranes 3%
• Genes 2%

Engineering & Materials Science

• Antigen-Presenting Cells 100%
• T-cells 75%
• Blood 46%
• Tumors 34%
• Antigens 22%
• Viruses 13%
• Gene therapy 9%
• Monoclonal antibodies 8%
• Peptides 7%
• Molecules 5%
• Genes 5%
• Compliance 4%
• Membranes 4%
• Engineers 3%
• Costs 2%

Chemistry

• Antigen 42%
• Effector 18%
• Dinucleotide 18%
• Application 15%
• Peptide 9%
• Molecule 5%